[Invasive nosocomial pulmonary aspergillosis].
Immunodepressed patients, particularly those with neutropenia or bone marrow or organ grafts, are at risk of developing nosocomial invasive pulmonary aspergilosis. The favoring factors, early diagnostic criteria and curative treatment protocols are well known. Prognosis remains however quite severe with a death rate above 50%. Preventive measures are required for the treatment of these high-risk patients and epidemiology surveillance is needed in case of aspergillosis acquired in the hospital.
Germaud
P
P
Service de pneumologie, CHRU Nantes, Hôpital Laënnec, BP 1005, 44035 Nantes Cedex 01.
Haloun
A
A
D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D003428:Cross Infection / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D017053:Infection Control / Q000379:methods*; D008172:Lung Diseases, Fungal / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D009503:Neutropenia / Q000150:complications; D011379:Prognosis; D012307:Risk Factors
D000935:Antifungal Agents